Status:
SUSPENDED
COVID-19: A POC Test Under Research & Evaluation
Lead Sponsor:
LumiraDx UK Limited
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Collection of nasal/nasopharyngeal/throat swabs and blood samples from patients presenting at their designated care facility displaying symptoms of COVID-19 and undergoing a SOC SARS-CoV-2 test or tho...
Detailed Description
CAPTURE is a two-stage sample collection study to complete the development, calibration and performance evaluation phases of the LumiraDx Point of Care (POC) device for the detection of the SARS-CoV-2...
Eligibility Criteria
Inclusion
- Patient is at least 18 years of age.
- Patient meets either of the below categories:
- Patient is presenting with symptoms indicative of COVID-19 and will be completing SOC sampling for SARS-CoV-2 PCR testing. (Eligible for Arm A)
- Patient has had a confirmed positive SARS-CoV-2 PCR test result in the past. (Eligible for Arm B)
Exclusion
- The patient does not have the capacity to consent as determined by the Research Team (and the impartial witness if applicable).
- The patient is deemed to be unsuitable for research at the research teams' discretion.
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04408066
Start Date
April 30 2020
End Date
July 1 2024
Last Update
January 12 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom, E1 1BB
2
Homerton University Hospital NHS Foundation Trust
London, United Kingdom, E9 6SR
3
University College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2PG